Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study

Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1025-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Altretamine / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy*
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Random Allocation
  • Triazines / therapeutic use*
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Triazines
  • Doxorubicin
  • Cyclophosphamide
  • Altretamine
  • Fluorouracil

Supplementary concepts

  • CAF protocol